Evidence map›Paper›PMID 30451932›Full record

ArticleScientific reports2018

Access to high-impact mutations constrains the evolution of antibiotic resistance in soft agar.

Nour Ghaddar, Mona Hashemidahaj, Brandon L Findlay

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Two complementingRNA biology · 2025
    Article
  3. Sequential antibiotic exposure restores antibiotic susceptibility.The Journal of antimicrobial chemotherapy · 2025
    Article
  4. Article
  5. Tripartite Loops Reverse Antibiotic Resistance.Molecular biology and evolution · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Emergence of ResistantFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Nour GhaddarDepartment of Chemistry and Biochemistry, Concordia University, Montreal, Québec, Canada.
Mona HashemidahajDepartment of Chemistry and Biochemistry, Concordia University, Montreal, Québec, Canada.
Brandon L FindlayDepartment of Chemistry and Biochemistry, Concordia University, Montreal, Québec, Canada. brandon.findlay@concordia.ca.ORCID http://orcid.org/0000-0001-7083-2513
Concordia University · CAConcordia University · USJewish General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite widespread resistance to many important antibiotics, the factors that govern the emergence and prevalence of antibiotic-resistant bacteria are still unclear. When exposed to antibiotic gradients in soft agar plates measuring as little as 1.25 × 11 cm we found that Escherichia coli rapidly became resistant to representatives from every class of antibiotics active against Gram-negative bacteria. Evolution kinetics were independent of the frequency of spontaneous mutations that confer antibiotic resistance or antibiotic dose-response curves, and were only loosely correlated to maximal antibiotic concentrations. Instead, rapid evolution required unrealized mutations that could markedly decrease antibiotic susceptibility. When bacteria could not evolve through these "high-impact" mutations, populations frequently bottlenecked, reducing the number of cells from which mutants could arise and prolonging evolution times. This effect was independent of the antibiotic's mechanism of action, and may affect the evolution of antibiotic resistance in clinical settings.

Indexed as

AgarEvolution, MolecularMutationAnti-Bacterial AgentsDose-Response Relationship, DrugDrug Resistance, MicrobialEscherichia coliGenome, BacterialMicrobial Sensitivity TestsAgarAnti-Bacterial Agents

Identifiers

PMID30451932
PMCPMC6242871
OpenAlexW2901799624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.